Status:
COMPLETED
Efficacy of Evidence-Based PTSD Treatment Via Prebiotic Supplementation
Lead Sponsor:
Rush University Medical Center
Collaborating Sponsors:
Cures Within Reach
Conditions:
Post Traumatic Stress Disorder
Eligibility:
All Genders
Phase:
NA
Brief Summary
Posttraumatic stress disorder (PTSD) is a debilitating psychiatric disorder, which results from exposure to traumatic events. Veterans are more than twice as likely to suffer from PTSD compared to civ...
Eligibility Criteria
Inclusion
- Veterans who are participating in the Rush Road Home Program 2-week Intensive Outpatient Program (IOP) and have the ability to consent.
- Ability and willingness to consume up to two prebiotic bars daily and collect stool samples.
Exclusion
- Active suicidality or homicidality, current engagement in significant non-suicidal self harm, history of mania or psychosis, current eating disorders, and/or current substance use that would require medical observation if discontinued.
- Gastrointestinal disease: (1) prior intestinal resection, (2) history of GI disease (except for hiatal hernia, nonproton pump inhibitor requiring gastroesophageal reflux disease, or hemorrhoids), (3) known renal disease or abnormal liver function, (4) antibiotic use within the previous 12 weeks, (5) a plan to have a major change in dietary habits during the study.
- Allergy to almonds, flax seed or coconuts
Key Trial Info
Start Date :
June 6 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 5 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05424146
Start Date
June 6 2022
End Date
July 5 2023
Last Update
April 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612